Neonatal Glucose Screening Evaluation and Treatment: Difference between revisions
From Guide to YKHC Medical Practices
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
<br/>'''Management:''' | <br/>'''Management:''' | ||
<br/>'''Critical Times for Affected Patients:''' | <br/>'''Critical Times for Affected Patients:''' | ||
===Resources/References=== | |||
* [[media:Glucose_neonatal.pdf|Neonatal Glucose Screening YKHC Clinical Guideline]] | * [[media:Glucose_neonatal.pdf|Neonatal Glucose Screening YKHC Clinical Guideline]] | ||
[[:category:YKHC Guidelines]] | [[:category:YKHC Guidelines]] | ||
<br/>[[Practicing Medicine in Bush Alaska—Some ABCs|Common/Unique Medical Diagnoses]] | <br/>[[Practicing Medicine in Bush Alaska—Some ABCs|Common/Unique Medical Diagnoses]] | ||
Revision as of 04:57, 25 September 2020
Pathophysiology:
Inheritance:
Demographics:
Signs/Symptoms:
Diagnosis:
Management:
Critical Times for Affected Patients:
